165 related articles for article (PubMed ID: 21454200)
1. Associated malignancies in patients with Waldenström's macroglobulinemia and their kin.
Hanzis C; Ojha RP; Hunter Z; Manning R; Lewicki M; Brodsky P; Ioakimidis L; Tripsas C; Patterson CJ; Sheehy P; Treon SP
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):88-92. PubMed ID: 21454200
[TBL] [Abstract][Full Text] [Related]
2. Familial Waldenstrom's macroglobulinemia and relation to immune defects, autoimmune diseases, and haematological malignancies--A population-based study from northern Sweden.
Brandefors L; Kimby E; Lundqvist K; Melin B; Lindh J
Acta Oncol; 2016; 55(1):91-8. PubMed ID: 26559865
[TBL] [Abstract][Full Text] [Related]
3. Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.
Morra E; Varettoni M; Tedeschi A; Arcaini L; Ricci F; Pascutto C; Rattotti S; Vismara E; Paris L; Cazzola M
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):700-3. PubMed ID: 24070824
[TBL] [Abstract][Full Text] [Related]
4. Familial Waldenstrom's macroglobulinemia.
McMaster ML
Semin Oncol; 2003 Apr; 30(2):146-52. PubMed ID: 12720125
[TBL] [Abstract][Full Text] [Related]
5. Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994.
Groves FD; Travis LB; Devesa SS; Ries LA; Fraumeni JF
Cancer; 1998 Mar; 82(6):1078-81. PubMed ID: 9506352
[TBL] [Abstract][Full Text] [Related]
6. Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Hunter ZR; Kanan S; Meid K; Treon SP
Cancer; 2015 Jul; 121(13):2230-6. PubMed ID: 25757851
[TBL] [Abstract][Full Text] [Related]
7. Characterization of familial Waldenstrom's macroglobulinemia.
Treon SP; Hunter ZR; Aggarwal A; Ewen EP; Masota S; Lee C; Santos DD; Hatjiharissi E; Xu L; Leleu X; Tournilhac O; Patterson CJ; Manning R; Branagan AR; Morton CC
Ann Oncol; 2006 Mar; 17(3):488-94. PubMed ID: 16357024
[TBL] [Abstract][Full Text] [Related]
8. Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: a preliminary study.
Ojha RP; Hanzis CA; Hunter ZR; Greenland S; Offutt-Powell TN; Manning RJ; Lewicki M; Brodsky PS; Ioakimidis L; Tripsas CK; Patterson CJ; Sheehy P; Singh KP; Treon SP
Cancer Epidemiol; 2012 Jun; 36(3):294-7. PubMed ID: 22099500
[TBL] [Abstract][Full Text] [Related]
9. Incidence of lymphoplasmacytic lymphoma/Waldenström's macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996-2003.
Iwanaga M; Chiang CJ; Soda M; Lai MS; Yang YW; Miyazaki Y; Matsuo K; Matsuda T; Sobue T
Int J Cancer; 2014 Jan; 134(1):174-80. PubMed ID: 23784625
[TBL] [Abstract][Full Text] [Related]
10. Familial disease predisposition impacts treatment outcome in patients with Waldenström macroglobulinemia.
Treon SP; Tripsas C; Hanzis C; Ioakimidis L; Patterson CJ; Manning RJ; Sheehy P; Turnbull B; Hunter ZR
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):433-7. PubMed ID: 23084402
[TBL] [Abstract][Full Text] [Related]
11. Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.
Arcaini L; Varettoni M; Boveri E; Orlandi E; Rattotti S; Zibellini S; Merli M; Lucioni M; Rizzi S; Gotti M; Morello L; Pascutto C; Paulli M
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):103-5. PubMed ID: 21454204
[TBL] [Abstract][Full Text] [Related]
12. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
13. Balancing risk versus benefit in the treatment of Waldenström's Macroglobulinemia patients with nucleoside analogue-based therapy.
Leleu X; Tamburini J; Roccaro A; Morel P; Soumerai J; Lévy V; Wemeau M; Balkaran S; Poulain S; Hunter ZR; Ghobrial IM; Treon SP; Leblond V
Clin Lymphoma Myeloma; 2009 Mar; 9(1):71-3. PubMed ID: 19362978
[TBL] [Abstract][Full Text] [Related]
14. Waldenstrom's macroglobulinemia terminating in acute myeloid leukemia.
Khalid S; Adil SN; Khurshid M
J Pak Med Assoc; 2006 Jun; 56(6):291-2. PubMed ID: 16827257
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetics of familial Waldenstrom's macroglobulinemia: in pursuit of an understanding of genetic predisposition.
McMaster ML; Giambarresi T; Vasquez L; Goldstein AM; Tucker MA
Clin Lymphoma; 2005 Mar; 5(4):230-4. PubMed ID: 15794854
[TBL] [Abstract][Full Text] [Related]
16.
Poulain S; Roumier C; Bertrand E; Renneville A; Caillault-Venet A; Doye E; Geffroy S; Sebda S; Nibourel O; Nudel M; Herbaux C; Renaud L; Tomowiak C; Guidez S; Tricot S; Roche-Lestienne C; Quesnel B; Preudhomme C; Leleu X
Clin Cancer Res; 2017 Oct; 23(20):6325-6335. PubMed ID: 28754818
[No Abstract] [Full Text] [Related]
17. A review of Waldenstrom's macroglobulinemia.
McDermott MK; Bell EM
Clin J Oncol Nurs; 1999 Jul; 3(3):107-11. PubMed ID: 10690041
[TBL] [Abstract][Full Text] [Related]
18. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C viral infection is not associated with Waldenström's macroglobulinemia.
Leleu X; O'Connor K; Ho AW; Santos DD; Manning R; Xu L; Hatjiharissi E; Moreau AS; Branagan AR; Hunter ZR; Dimmock EA; Soumerai J; Patterson C; Ghobrial I; Treon SP
Am J Hematol; 2007 Jan; 82(1):83-4. PubMed ID: 16955461
[TBL] [Abstract][Full Text] [Related]
20. Diffuse interstitial lung disease as a first manifestation of Waldenström's macroglobulinemia: case report and review of the literature.
Consuegra A; Marcos PJ; Vázquez R; Pombo J; Debén G; Verea-Hernando H
Arch Bronconeumol; 2014 Apr; 50(4):151-3. PubMed ID: 24629759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
